Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors-Reference-Cited by-同舟云学术

Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors

Published:2020-06-25 Issue: Volume: Page:annrheumdis-2020-218152
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Jovani Vega^ORCID,Calabuig Irene^ORCID,Peral-Garrido Maria Luisa,Tovar-Sugrañes Ernesto,López-González María-del-Carmen,Bernabeu Pilar,Martínez Agustín,Esteve-Vives Joaquim,León-Ramírez Jose-Manuel,Moreno-Perez Oscar,Boix Vicente,Gil Joan,Merino Esperanza,Vela Paloma,Andrés Mariano^ORCID

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference7 articles.

1. D’Silva KM , Serling-Boyd N , Wallwork R , et al . Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’. Ann Rheum Dis 2020;16:annrheumdis-2020-217888.doi:10.1136/annrheumdis-2020-217888

2. RH D , Liang LR , Yang CQ , et al . Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J 2020;55:2000524.

3. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

4. Favalli EG , Ingegnoli F , Cimaz R , et al . What is the true incidence of COVID-19 in patients with rheumatic diseases? Ann Rheum Dis 2020;22:annrheumdis-2020-217615.doi:10.1136/annrheumdis-2020-217615

5. Haberman R , Axelrad J , Chen A , et al . Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York. N Engl J Med 2020;29:NEJMc2009567.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hospitalization, disease severity and mortality rates of patients with inflammatory rheumatic diseases as compared with the normal population in the second wave of SARS-CoV-2 infections;Rheumatology;2023-12-06

2. In silico Method Potential Therapeutic Use of Janus Kinase Inhibitors as Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors;Journal of the Scientific Society;2023-09

3. COVID-19 and Pediatric Rheumatology: A Comprehensive Study from a Leading Tertiary Center in Saudi Arabia;Journal of Epidemiology and Global Health;2023-08-18

4. Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2;Viruses;2023-06-27

5. A prospective analysis of the long-term impact of the COVID-19 pandemic on well-being and health care among children with a chronic condition and their families: a study protocol of the KICK-COVID study;BMC Pediatrics;2023-03-22